Plaintiff: Merz Pharmaceuticals
Defendant: Par
Pharma
Case Number: 1:12-cv-01723
Date Filed: December 17, 2012
Patents-in-Suit: US7638552 and US7816396
Patent Number
Current Assignee[*]
|
Issued Date
|
Expiration Date[†]
|
Title
|
|
|
Dec 29, 2009
|
Aug 20, 2023
|
Method for increasing
the bioavailability of glycopyrrolate
|
|
|
Oct 19,
2010
|
Aug 20,
2023
|
Method for increasing the
bioavailability of glycopyrrolate
|
Table information
sourced from Maxval’s Assignment Database.
The ‘552 patent describes a method of increasing the
bioavailability of glycopyrrolate by administration of a therapeutically
effective amount of glycopyrrolate without food. The invention also provides a
kit comprising a pharmaceutical composition comprising a therapeutically
effective amount of glycopyrrolate and a pharmaceutically acceptable carrier,
prescribing information including advice regarding the administration of
glycopyrrolate without food to improve bioavailability, and a container.
The ‘396 patent describes a method of treating sialorrhea in
a human patient comprising orally administering glycopyrrolate in a liquid
solution under fasted conditions.
About the Parties:
Merz is an international healthcare
company specializing in the research, development and marketing of
pharmaceuticals for the treatment of neurological and psychiatric diseases.
Par Pharma develops, manufactures and markets
generic and branded specialty pharmaceuticals.
As in Compliant:
Merz is the current holder[‡] of the New
Drug Application (NDA) no. 22-571 for Cuvposa® (source: Maxval’s Patent Marker) that is
approved by FDA. Cuvposa is
indicated to reduce chronic severe drooling in patients aged 3 to 16 years with
neurologic conditions. The complaint is filed against the defendant for seeking
FDA approval with the Abbreviated New
Drug Application (ANDA) no. 204438 to market a generic version of Cuvposa® (Par’s Proposed Product) that infringes
the above patents.
If you are interested in knowing more about the cases filed,
please contact us. To get alerts on cases filed,
subscribe to our Litigation Alerts.
[*]MaxVal offers Patent
Assignment Alert service where subscribers receive email alerts when
assignments relating to target applications, patents or entities of interest
are recorded.
[†]Expected
expiration date. Patent Term
Estimator is a free web-based tool that automatically calculates patent terms and
expiration dates for U.S. utility patents.
[‡]Patent Marker provides an online environment for patentees to
virtually mark products and search for patent related information.
No comments:
Post a Comment